Multidisciplinary training in cardiovascular engineering

心血管工程多学科培训

• 批准号: 10208935
• 负责人: VICTOR H BAROCAS
• 金额: $ 25.91万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10208935
• 关键词: Cardiovascular system; Engineering; Training; multidisciplinary

Project Summary In spite of great effort and many medical advances, heart disease remains the leading cause of death in the United States causing 1 in 4 deaths annually. In 2010, the treatment of these diseases accounted for about $1 of every $6 spent on healthcare in the U.S. The demand for cardiovascular devices is only going to increase as the incidence of cardiovascular diseases rises, the population ages, and medical technology continues to advance. To help meet this demand, we need biomedical engineers with the appropriate advanced multidisciplinary education and training. The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)'s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research: • complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts); • complete a clinical immersion in one of the UMN cardiovascular clinics; • attend an innovation lecture series (offered through the UMN Medical Devices Center); • attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations; and • attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law. We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.

项目概要 尽管付出了巨大的努力并取得了许多医学进步，心脏病仍然是导致人类健康的主要原因。 在美国，每年有四分之一的人死亡。 2010年，这些疾病的治疗 在美国，每 6 美元的医疗保健支出中，用于疾病的支出约占 1 美元。 随着心血管疾病的发病率增加，心血管设备只会增加 人口增长，人口老龄化，医疗技术不断进步。为了帮助满足这个 需求，我们需要具有适当的先进多学科的生物医学工程师 教育和培训。拟议的 T32 培训计划专门设计用于教育、 在生物医学工程方面培训并体验式提高博士生的能力 专门让临床医生和临床医生科学家参与其中的多学科环境 结尾。在他们作为实习生参加博士前两年的学习期间 明尼苏达大学（UMN）设立的生物医学工程研究生项目，六 每年的学员将通过多种方式与强大的培训师进行互动，包括这些 除了开始博士研究之外的独特活动： • 完成高级心脏生理学和解剖学课程（由 UMN-Medtronic Visible Heart Lab 合作和心血管设备的领导者 （由当地心血管器械公司专家授课）； • 在 UMN 心血管诊所之一完成临床实践； • 参加创新系列讲座（通过 UMN 医疗器械中心提供）； • 参加每月一次的临床焦点午餐会，邀请临床医生介绍具体情况 心血管疾病和相关医疗设备限制；和 • 参加每月一次的专业发展午餐会，并邀请演讲者发表演讲 广泛的职业机会，包括医疗技术公司研发、FDA 和专利法。 我们将招募多元化的学员，并且该计划将定期由 咨询委员会，以确保其在各方面取得成功。我们预计由此产生的 我们的学员的多学科研究和视角将使他们能够满足 通过推动未来技术进步（无论是研发）来满足上述需求 心血管设备公司的工程师、联邦实验室的设备监管人员或 教授们领导自己的心血管工程研究项目。